Flexion Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 44 rows, 44 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-02-18: Reporting owner Novo A/S; Form 4; Security SERIES B PREFERRED STOCK; Transaction C Conversion of derivative security.
- 2014-02-18: Reporting owner Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2014-02-18: Reporting owner Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2014-02-18: Reporting owner Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-02-18 | Novo A/S | 4 | SERIES B PREFERRED STOCK Derivative · Direct | C Conversion of derivative security | −8,868,393 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −16,558,351 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −97,797 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −2,900,000 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −3,135,165 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Versant Venture Capital III, L.P. | Versant Side Fund III, L.P. | Versant Development Fund III, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −18,512 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Tordjman Rafael Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Sofinnova Capital VI FCPR | C Conversion of derivative security | −13,124,932 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Tordjman Rafael Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By Sofinnova Capital VI FCPR | C Conversion of derivative security | −2,116,562 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Sofinnova Partners SAS 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −13,124,932 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Sofinnova Partners SAS 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,116,562 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Schwab Andrew J. Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | C Conversion of derivative security | −10,499,946 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Schwab Andrew J. Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | C Conversion of derivative security | −1,693,249 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | PFIZER INC 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −11,812,438 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | PFIZER INC 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,904,905 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | COLELLA SAMUEL D Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | C Conversion of derivative security | −19,556,148 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | COLELLA SAMUEL D Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | C Conversion of derivative security | −3,153,677 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Clayman Michael D. Director, Officer (President and CEO) | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Development Fund III, LLC | C Conversion of derivative security | −2,900,000 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Bolzon Bradley J PhD Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | C Conversion of derivative security | −19,556,148 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Bolzon Bradley J PhD Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | C Conversion of derivative security | −3,153,677 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | Bodick Neil Officer (Chief Medical Officer) | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Development Fund III, LLC | C Conversion of derivative security | −2,900,000 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | 5AM Ventures II LP | 5AM CO-INVESTORS II LP 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | C Conversion of derivative security | −10,499,946 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-18 | 5AM Ventures II LP | 5AM CO-INVESTORS II LP 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | C Conversion of derivative security | −1,693,249 0 owned after | $0.00 | 2014-02-20 | |
| 2014-02-11 holding as of filing | Novo A/S | 3 | SERIES B PREFERRED STOCK Derivative · Direct | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Versant Development Fund III, L.P. | Versant Side Fund III, L.P. | Versant Venture Capital III, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Versant Development Fund III, L.P. | Versant Side Fund III, L.P. | Versant Venture Capital III, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Versant Development Fund III, L.P. | Versant Side Fund III, L.P. | Versant Venture Capital III, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Versant Development Fund III, L.P. | Versant Side Fund III, L.P. | Versant Venture Capital III, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Versant Development Fund III, L.P. | Versant Side Fund III, L.P. | Versant Venture Capital III, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Tordjman Rafael Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Sofinnova Capital VI FCPR | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Tordjman Rafael Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By Sofinnova Capital VI FCPR | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Sofinnova Partners SAS 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Sofinnova Partners SAS 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Schwab Andrew J. Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Schwab Andrew J. Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | PFIZER INC 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | PFIZER INC 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | COLELLA SAMUEL D Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | COLELLA SAMUEL D Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Clayman Michael D. Director, Officer (President and CEO) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Bolzon Bradley J PhD Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Bolzon Bradley J PhD Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with Versant Ventures | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Bodick Neil Officer (Chief Medical Officer) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | 5AM Ventures II LP | 5AM CO-INVESTORS II LP 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | Holding | no price filed | 2014-02-11 | ||
| 2014-02-11 holding as of filing | 5AM Ventures II LP | 5AM CO-INVESTORS II LP 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By entities affiliated with 5AM Ventures II, L.P. | Holding | no price filed | 2014-02-11 |